Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Applying for Breakthrough seems very close now

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon May 11, 2023 9:51am

143 Views

Post# 35442874

RE:RE:RE:RE:RE:RE:Applying for Breakthrough seems very close now

Rumpl3StiltSkin wrote: Exactly Gents,

TLT has had FT designation for some time now. They now have the CR %s and number of patients treated to apply for AA. BTD would be another great NR for them, should speed things up considerably. But really they don't NEED it to move towards AA, Now... If they wanted to...

I feel sorry for IBRX investors, but perhaps we may get to market before them and that would mean an even greater market potential for us.? Time will tell

<< Previous

Bullboard Posts

Next >>

Fobi AI responds to cease trade order, filing delay “disappointing”